Page 1602 - Small Animal Internal Medicine, 6th Edition
P. 1602

1574   Index


            Sinus rhythms, 37, 40f    Spinal cord (Continued)  Splenomegaly (Continued)  Strabismus, 1055–1057, 1058f, 1111f
            Sinus tachycardia, 37, 39b, 40f  prognosis for, 1135  hyperplastic, 1411, 1412t  Strain rate, 32
             causes of, 79–80          upper motor neuron signs, 1040, 1040f  imaging of, 1415–1416  Stranguria, 735–736, 736f
                                        treatment of, 1133–1134, 1134f
  VetBooks.ir  Skin infections, 1445  Spinal cord ataxia, 1046b  infiltrative, 1412t, 1413  Streptococcus pyogenes, 1542
                                                                 infectious, 1412t
                                                                                         Streptococcus group A, 1533t–1535t, 1542
            Skeletal muscle, 1042
                                       white matter of, 1039
                                                                                         Streptokinase, 227b, 229
                                                                 inflammatory, 1412t
            Sleep disorders, 1107–1108
            Slide agglutination test, 1215–1216
            Small airway obstruction, 329b  Spinal cord disorders, 1041b, 1130–1156  localized, 1411  Streptomycin, 1461–1462
                                       acute intervertebral disk disease
                                                                                         “Stress” ulceration, 470
                                                                 management of, 1418
            Small intestine             cervical disk extrusion, 1138t, 1139  nonneoplastic causes of, 1413–1414  Stress-induced hyperglycemia, 833, 835,
             bacterial overgrowth, antibiotics for,   clinical features of, 1136, 1136f  pathogenesis of, 1411–1414  837
                1440t, 1442             description of, 1135–1141  pathogenetic classification of, 1412t  Stress-induced neutrophilia, 1376
             contrast-enhanced studies of, 422–423,   diagnostic approach, 1136–1137,   signs of, 1410  Stridor, 271, 285
                425f                       1137f–1139f         Split heat cycle, 953–954  Stroke. see Vascular accidents
             diarrhea, 399t, 400f       magnetic resonance imaging of,   Spondylomyelopathy, 1065  Stromal tumor, 503
               dietary-responsive, 491–492  1137               Spontaneous intracranial hemorrhage,   Strongyloides stercoralis, 1533t–1535t,
             enteropathy, antibiotic-responsive, 492  myelography for, 1137, 1138f  1076    1536
             imaging of, 419–423        treatment of, 1137–1141  Spontaneous nystagmus, 1109  Strongyloidiasis, 488
             neoplasms of, 502–503     atlantoaxial instability, 1142, 1154  Spontaneous pneumothorax, 364–365,   Struvite crystals, 668–669, 669f
             ultrasonography of, 420–422, 421f  cauda equina syndrome, 1149–1151,   376–377, 377f  Struvite uroliths, 718–719, 719f
            Small stature, 756b           1149f–1151f          Sporanox. see Itraconazole  Strychnine, 1099b
            Sneezing, 244–245          cervical spondylomyelopathy,   Sporothrix schenckii, 1503t, 1542f  Stud dogs
            Sodium                        1151–1153, 1152f–1153f  Sporothrix spp., 1533t–1535t, 1541  benign prostatic hyperplasia in,
             fractional clearance of, 664  common, 1131b       Sporozoites, 1520             1001–1003, 1002f, 1034t–1036t
             hypernatremia. see Hypernatremia  degenerative myelopathy, 1148–1149  Squamous cell carcinoma  prostatic disorders in, 1001–1005
             hyponatremia. see Hyponatremia  fibrocartilaginous embolism,   metastasis of, 1290t  testicular neoplasia in, 996–997,
             retention of, 684            1141–1142              oral cavity, 448t           996f–997f
            Sodium bicarbonate, 690–691, 921t,    general considerations in, 1130  Squamous epithelial cells, 666, 667f  Subaortic stenosis, 16–17
               934t                    hemorrhage, 1135        SRY gene, 1005              β-blockers for, 107
            Sodium levothyroxine       infarction, 1135        ST segment                  clinical features of, 106
             hypothyroidism treated with, 783–784,   traumatic disk extrusions, 1141  abnormalities of, 46–47, 48b  diagnosis of, 106–107
                783b, 896t–897t       Spinal cord dysfunction    definition of, 26t        dog breeds affected by, 102t
             thyrotoxicosis caused by, 784–785  peracute or acute, 1133–1142  pseudodepression of, 47  echocardiography of, 106–107, 106f
            Sodium nitroprusside, 63   progressive. see Progressive spinal cord   Staining of specimens, 1258  etiology of, 105–106
            Sodium pentobarbital, 1105b   dysfunction          Stanozolol, 336             pathophysiology of, 105–106
            Soft tissue infections, 1439t, 1445  Spinal dysraphism, 1155–1156  Staphylococcus pseudointermedius, 1445  prognosis for, 107
            Soft-coated Wheaton paroxysmal   Spinal muscular atrophy, 1164  Statins, 913   radiographic findings, 103t
               dyskinesia, 1106       Spinal pain, 1053f–1054f, 1134t, 1143  Status epilepticus, 1098, 1104–1105,   severity of, 106
            Solitary lymphadenopathy, 1407–1408,   Spinal radiographs, 1064  1105b         treatment of, 107
               1410t                  Spinal reflexes          Steatorrhea, 620          Subarachnoid space, 1065
            Solitary lymphoma, 1307    bulbourethral reflex, 1049t, 1050  Stenotic nares, 279, 279f  Subclinical bacteriuria, 705t, 706
            Solitary mass, 1288–1289, 1289f  crossed extensor reflex, 1049–1050  Sterile hemorrhagic cystitis, 1284  Subfertility, infertility versus, 1003
            Solu-Delta-Cortef. see Prednisolone  cutaneous trunci reflex, 1049t,   Sternal lymphadenopathy, 926  Sublumbar lymphadenopathy, 1411f
            Somatostatin, 850b, 852, 896t–897t  1050–1051, 1051f  Steroid-responsive meningitis-arteritis,   Submucosal urethral bulking agents, 735
            Somogyi response, 825–826, 826f  evaluation of, 1047–1051  1118f, 1119–1123, 1119b  Sucralfate, 439–440, 439t, 515t–517t,
            Sotalol, 83–84, 95         overview of, 1047, 1049t  Steroid-responsive neutropenia, 1244  1255t–1256t
             in cats, 90t–91t          patellar reflex, 1047, 1049f, 1049t  Steroid-responsive tremor syndrome,   Sudden acquired retinal degeneration,
             characteristics of, 94t, 95  pelvic limb withdrawal reflex,   1122             1087
             in dogs, 90t–91t             1047–1049, 1049f, 1049t  Stertor, 245, 271–272, 285  Sulfadimethoxine, 444t, 515t–517t
             dosage of, 90t–91t        perineal reflex, 1049t, 1050, 1051f  Stethoscope, traditional, 7, 7f  Sulfasalazine, 515t–517t. see also
            Space-occupying lesions, of pharynx,   sciatic reflex, 1049, 1049t, 1050f  Stifle, arthrocentesis method in, 1191f  Salicylazosulfapyridine
               271–272                 thoracic limb withdrawal reflex, 1049,   Stomach. see also specific gastric entries  Sulfonamides, 781, 1439t
            Specificity, 1432–1433        1050f                  endoscopy of, 428f      Sulfonylureas, 835
            Specimens                 SPINK1, 621                imaging of, 419–423     Summation gallop, 9
             bronchoalveolar lavage, 309  Spironolactone         radiographic imaging of, 420–422,   Superficial necrolytic dermatitis, 615
             tracheal wash, 298, 301f  chronic heart failure treated with, 64t,   421f, 427f  Suprascapular nerve, 1158t
            Sperm cells, 1004f            67                     ultrasonography of, 420–422  Supraventricular premature complexes,
            Sperm ejaculated, increase, 1034t–1036t  dilated cardiomyopathy treated with,   Stomach disorders, 462–473. see also   39
            Spermatogenesis, defects of, 1005, 1005f  147         specific gastric entries  Supraventricular tachyarrhythmias
            Sperm-rich fluid, 945–946  onset of action, 67       bilious vomiting syndrome, 470  acute therapy for, 80–82
            Spherocytes, 1233, 1234t, 1346–1348,   Spleen        gastric antral mucosal hypertrophy,   algorithm for, 81f
               1346f                   abscesses of, 1412–1413      465, 466f              mechanisms of, 78
            Spherocytosis, 1231, 1345t  biopsy of, 1416–1417     gastric dilation/volvulus. see Gastric   oral therapy for, 80
            Spina bifida, 1155         blood storage in, 1413       dilation/volvulus      refractory, 80
            Spinal arachnoid diverticula, 1147–1148  enlargement of. see Splenomegaly  gastric foreign objects, 466–467  vagal maneuver for, 82
            Spinal articular cysts, 1147  functions of, 1407     gastric outflow obstruction/gastric   Supraventricular tachycardias
            Spinal cord                masses of, 1413, 1415f       stasis, 465–470        description of, 80
             anatomy of, 1039–1041     radionuclide imaging of, 1416  gastritis. see Gastritis  electrocardiography of, 39
             fractures of, 1134f       torsion of, 1413, 1416f   gastrointestinal ulceration/erosion,   reentrant, 39
             gray matter of, 1039     Splenectomy, 1228             470–471, 471f        Surgery
             lesions of, 1041, 1130–1133  Splenic fibrohistiocytic nodule,   Helicobacter-associated disease, 464,   canine thyroid neoplasia treated with,
               C1-C5, 1130, 1131t       1413–1414                   464f                     803
               C6-T2, 1130–1131, 1131t  Splenitis, 1412–1413, 1412t  idiopathic gastric hypomotility,   cardiac tumors treated with, 188
               diagnostic approach, 1132–1133  Splenomegaly, 1407–1419  469–470            cervical spondylomyelopathy treated
               L4-S3, 1131t, 1132      anemia associated with, 1414–1415  infiltrative gastric diseases, 471–472  with, 1153
               neurologic findings in, 1131t  approach to, 1414–1418  neoplasms, 471–472   heartworm disease treated with, 207
               T3-L3, 1131, 1131f, 1131t  classification of, 1412t  Ollulanus tricuspis causing, 465  hyperthyroidism treated with,
             lower motor neuron signs, 1039–1040,   clinical features of, 1414  partial or intermittent chronic gastric   798–799, 798b
                1039f, 1040t           clinicopathologic features of,   volvulus, 469, 469f  Sustained atrial tachycardia, 42f
             neoplasia of, 1142           1414–1415              Physaloptera rara causing, 464–465  Swabs, nasal, 254, 259f
             segments of, 1039f, 1132f, 1132t  congestive, 1412t  pyloric stenosis, 465  Swallowing reflex, 1060
             sensory pathways of, 1040–1041  cytologic evaluation of, 1416, 1417f  pythiosis, 420f, 472  Symmetric dimethylarginine, 659
             trauma to                 definition of, 1411     Stomatitis, 450, 450b     Sympathomimetic drugs, 98
               clinical features of, 1133  description of, 1382  calicivirus-induced, 1496  canine chronic bronchitis treated with,
               description of, 1133–1135  diffuse, 1409–1410     caudal, 1439f               332
               diagnosis of, 1133      disorders associated with, 1342t  Stomatocytosis, 1347t  in cats, 90t–91t, 327b
               flowchart for, 1134f    etiology of, 1411–1414  Stool-softening agents, 445t  in dogs, 90t–91t, 327b
   1597   1598   1599   1600   1601   1602   1603   1604   1605   1606